The role of intellectual property rights on access to medicines in the WHO African region: 25 years after the TRIPS agreement

摘要

Most recent are assembly decisions WHA 71(8) of 2018 on ‘Addressing the global shortage of, and access to, medicines and vaccines’, which requested the DG to “elaborate a roadmap report, in consultation with Member States, outlining the programming of WHO’s work on access to medicines and vaccines including activities, actions and deliverables for the period 2019 – 2023; and WHA71(9) of 2018 on the ‘Global strategy and plan of action on public health, innovation and intellectual property (GSPOA-PHI): overall programme review’, which requested the DG to “implement the recommendations addressed to the Secretariat … in an implementation plan, consistent with the global strategy and plan of action on public health, innovation and intellectual property”. Additionally, in 2019 resolution WHA72.8 on ‘Improving the transparency of markets for medicines, vaccines, and other health products’, requested the DG to “continue supporting existing efforts to determine patent status of health products and promote publicly available user-friendly patent status information databases for public health actors, in line with the GSPOA-PHI and to work with other relevant international organizations and stakeholders to improve international cooperation, avoid duplication of work, and promote relevant initiatives”.